Richard E. Lowenthal - 20 Aug 2024 Form 4 Insider Report for ARS Pharmaceuticals, Inc. (SPRY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 Aug 2024, 18:47:25 UTC
Prior SEC filing
15 Aug 2024
Next SEC filing
12 Sep 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kathleen Scott, Attorney-in-Fact

Key filing fact

Richard E. Lowenthal filed Form 4 for ARS Pharmaceuticals, Inc. (SPRY) on 21 Aug 2024.

Key facts

  • This page summarizes Richard E. Lowenthal's Form 4 filing for ARS Pharmaceuticals, Inc. (SPRY).
  • 6 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 21 Aug 2024, 18:47.

Change

  • Previous filing in this sequence was filed on 15 Aug 2024.
  • Current net transaction value: -$1,502,587.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

SPRY transaction

Common Stock

Sale

Transaction value
$530,408
Shares
-35,944
Change %
-2.3%
Price
$14.76
Shares after
1,511,503
Date
20 Aug 2024
Ownership
By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020
Footnotes
F1, F2, F3
SPRY transaction

Common Stock

Sale

Transaction value
$183,545
Shares
-11,756
Change %
-0.78%
Price
$15.61
Shares after
1,499,747
Date
20 Aug 2024
Ownership
By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020
Footnotes
F1, F3, F4
SPRY transaction

Common Stock

Sale

Transaction value
$37,395
Shares
-2,300
Change %
-0.15%
Price
$16.26
Shares after
1,497,447
Date
20 Aug 2024
Ownership
By Sarina Tanimoto Charitable Remainder UniTrust Dated January 7, 2020
Footnotes
F1, F3, F5
SPRY transaction

Common Stock

Sale

Transaction value
$534,461
Shares
-36,216
Change %
-2.3%
Price
$14.76
Shares after
1,512,283
Date
20 Aug 2024
Ownership
By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006
Footnotes
F1, F6, F7
SPRY transaction

Common Stock

Sale

Transaction value
$180,028
Shares
-11,523
Change %
-0.76%
Price
$15.62
Shares after
1,500,760
Date
20 Aug 2024
Ownership
By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006
Footnotes
F1, F7, F8
SPRY transaction

Common Stock

Sale

Transaction value
$36,748
Shares
-2,261
Change %
-0.15%
Price
$16.25
Shares after
1,498,499
Date
20 Aug 2024
Ownership
By Lowenthal-Tanimoto Family Trust U/A DTD 4/3/2006
Footnotes
F1, F7, F9
SPRY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,315,313
Date
20 Aug 2024
Ownership
Direct
SPRY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,446,494
Date
20 Aug 2024
Ownership
By Richard Lowenthal Charitable Remainder UniTrust Dated January 7, 2020
Footnotes
F10
SPRY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,407,847
Date
20 Aug 2024
Ownership
By Spouse
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 10 footnotes

Footnote F1

The shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 31, 2023.

Footnote F2

The weighted average sale price for the transaction report was $14.7565 and the range of prices were between $14.09 and $15.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares old at each separate price will be provided.

Footnote F3

The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

Footnote F4

The weighted average sale price for the transaction report was $15.6129 and the range of prices were between $15.10 and $16.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares old at each separate price will be provided.

Footnote F5

The weighted average sale price for the transaction report was $16.2589 and the range of prices were between $16.15 and $16.36. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares old at each separate price will be provided.

Footnote F6

The weighted average sale price for the transaction report was $14.7576,and the range of prices were between $14.09 and $15.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares old at each separate price will be provided.

Footnote F7

The shares are held in trust for the benefit of the Reporting Person and his spouse. The Reporting Person and his spouse are trustees of the trust.

Footnote F8

The weighted average sale price for the transaction report was $15.6234,and the range of prices were between $15.10 and $16.09. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares old at each separate price will be provided.

Footnote F9

The weighted average sale price for the transaction report was $16.2532 and the range of prices were between $16.12 and $16.34. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares old at each separate price will be provided.

Footnote F10

The Reporting Person is trustee of the trust.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .